Neurocrine Biosciences Announces Appointment of Christine A. Poon to Board of Directors
![img: Featured](/wp-content/themes/neurocrine/assets/img/feature-5.jpg)
SAN DIEGO , July 11, 2023 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it appointed Christine A. Poon , a business leader with extensive experience in the pharmaceutical industry, to its Board of Directors. ” Christine Poon brings a wealth of industry